InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,111.55
(
1.25%
)
US TECH 100
17,276.40
(
1.76%
)
Dow Jones
38,315.55
(
0.60%
)
Brent Oil
88.29
(
0.15%
)
Bitcoin
63,982.45
(
-0.78%
)
Post# of 13874
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Iam_in

Send PM Follow Ignore
Followers 2
Posts 266
Boards Moderated 0
Alias Born 08/12/2016

Iam_in

Re: None

Monday, 02/20/2017 4:24:50 AM

Monday, February 20, 2017 4:24:50 AM

Post# of 13874
Todays International Symposium on Acute Leukemias (ISAL) XVI in Munich, Germany.

Immune Pharmaceuticals (Gold Circle Member)

Satellite Symposium III: Monday, February 20, 2017: 12.45 - 13.45 (Lecture Hall III/IV)

"Reinforcing the Efficacy of Immunotherapy for the Maintenance of remission in AML with Ceplene"

Chair:
W. Hiddemann, Munich, DE

Opening Remarks:
W. Hiddemann, Munich, DE

12.50-13.10
K. Hellstrand, Gothenburg, SE
Role of Cytotoxic T Cells in Remission Maintenance with Ceplene/IL-2 Therapy in AML

13.10-13.15
Discussion

13.15-13.40
Rowe, J., Jerusalem, IL
Maintenance Therapy in AML

13.40-13.45
Discussion

Industry Sponsored Satellite Symposia
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up